Gene Therapy & Gene Editing sexy bubble deflation$SLDB 85$SGMO 73$AAVL 95$AGTC 90$SIGHT 80$AVRO 72$ABEO 70$VYGR 67$ADVM 63$ONCE 50$BOLD 50$RGNX 50$NITE 50$CLLS 65$NTLA 65$CRSP 60$EDIT 56from peakrece

Gene Therapy & Gene Editing sexy bubble deflation $SLDB -85% $SGMO -73% $AAVL -95% $AGTC -90% $SIGHT -80% $AVRO -72% $ABEO -70% $VYGR -67% $ADVM -63% $ONCE -50% $BOLD -50% $RGNX -50% $NITE -50% $CLLS -65% $NTLA -65% $CRSP -60% $EDIT -56% (from peak/rece

11:59 EST 7 Feb 2019 | Andy Biotech

Gene Therapy & Gene Editing sexy bubble deflation $SLDB -85% $SGMO -73% $AAVL -95% $AGTC -90% $SIGHT -80% $AVRO -72% $ABEO -70% $VYGR -67% $ADVM -63% $ONCE -50% $BOLD -50% $RGNX -50% $NITE -50% $CLLS -65% $NTLA -65% $CRSP -60% $EDIT -56% (from peak/recent high)

More From BioPortfolio on "Gene Therapy & Gene Editing sexy bubble deflation $SLDB -85% $SGMO -73% $AAVL -95% $AGTC -90% $SIGHT -80% $AVRO -72% $ABEO -70% $VYGR -67% $ADVM -63% $ONCE -50% $BOLD -50% $RGNX -50% $NITE -50% $CLLS -65% $NTLA -65% $CRSP -60% $EDIT -56% (from peak/rece"